StockWatch
·
INDIGO PAINTS LTD · QQ2 FY-2027 · THE CALL

Inventory shock masks growth; recovery expected H2 if geopolitics hold

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

Q2 FY27 resultsINDIGOPNTSIndigo Paints Ltd06 Nov 2026 · 6 min read
Verdict

Hold

confidence 6/10

Credibility

Grade C

Jodhpur timeline on track, inventory accounting explanation credible, margin recovery claims unproven. Avoids numeric guidance.

Short-term outlook

Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Revenue +15% YoY but PAT -47% due to inventory accounting shock now passing. Management credibly frames Q2 as temporary; October recovery narrative is early-stage. Jodhpur ramp real but risk of crude volatility and price-hike volume elasticity unproven.

₹358.8 Cr

Revenue · +15% YoY

₹13.4 Cr

Reported PAT · −47% YoY

Compressing

Margins · vs guidance: Corroborated

Did the claims hold up?

Management's claims vs. the numbers

Gross margin collapsed 660 bps due to high-cost raw material inventory expensed in Q2

MET

Q2 gross margin 38.5% vs 45.1% PY = 660 bps decline. Inventory impact acknowledged; H1 margin 41.9% vs 45.6% = 370 bps (cleaner view).

Stand-alone revenue growth 14.1% YoY in Q2; industry grew 12-14%

MET

Consolidated Q2 revenue 358.7 Cr (+15% YoY per call, +15% per delivered). Marginal industry outperformance claimed.

October 2026 record sales, highest Y-on-Y monthly growth in 3-4 years

Unverified

Stated on call post-Q2 close (Nov 2). Not verified in Q2 results.

Jodhpur water-based plant will be fully operational by end of November 2026

MET

Trial production started late Sept; expects declaration of trial completion by end-Nov, definitely Dec. Concrete timeline but slightly fuzzy.

No future profitability shocks expected from Q3 onwards as inventory is behind us

OVERSTATED

Contingent on raw material price stability (crude at $110-115). If geopolitical flare-up repeats, volatility returns. Acknowledged as beyond control.

Earnings quality

What changed since the last call

Deltas vs. the prior call

Inventory burden now visible; prior call vague

Downgrade

Q1 FY27 benefited from low-cost inventory (EBITDA +42% YoY). Q2 reversed (-33% YoY) as high-cost stock expensed. No prior call predicted this swing.

October record sales claimed post-close

Upgrade

Stated on this call (Nov 2) that Oct had highest-ever monthly sales + Y-on-Y growth. Not in prior guidance but early signal of H2 recovery.

Guidance stance unchanged; no numeric targets

Neutral

Prior call: no formal FY27 target, aggressive growth + margin compression. This call: same narrative, no number guidance ('I hesitate to give a number').

The Q&A

Analysts pressed hard on 3 themes: (1) gross margin breakdown (Kapadia got detailed inventory explanation), (2) sustainability of growth claims (Roy challenged 2x-3x industry language), (3) recovery credibility (Akhilesh B pushed on demand elasticity to price hikes). Management held firm on inventory-as-anomaly but dodged number guidance, citing geopolitical risk.

The exchanges that mattered

H2 margin recovery expectations — Abneesh Roy, Nuvama

Answered

If industry grows 12-15% in Q3 and we can do 23-25%, margins should improve substantially. Q4 historical precedent: EBITDA 23%, so 'not very pessimistic'.

Competitive dynamics and market share — Abneesh Roy, Nuvama

Partial

Local player data unpublished. Industry leader tends to gain disproportionately on price hikes. Competitors recovering ground now. 'Slightly weak base' of prior 2 years helps industry leader bounce.

Inventory and margin breakdown — Prakash Kapadia, Entrust

Answered

Product mix (premiums weak in Q2 monsoon) accounts ~2.5%, raw material inventory accounts ~4%. Q3 mix recovers, inventory clears by Aug, margins normalize. Not expecting repeat.

Water plant timeline and trial completion — Deepak Juneja, Individual

Answered

Trial started late Sept. No permissions awaited (pollution, factory license, electric all in place). End-Nov target to declare trials over, definitely operational by Dec. Day-by-day debugging ongoing.

Raw material volatility and future shocks — Deepak Juneja, Individual

Answered

High-cost inventory already expensed in Aug. Crude now $110-115 stable. If crude goes up again, yes, could repeat. Hedging options not available for paint raw materials. Manage via inventory.

Price hike absorption and volume elasticity — Aniruddha Joshi, ICICI

Answered

Price hikes dictated by industry leader. Timing/magnitude determined by leader, not followers. Inflation does not cover exact products. Demand historically inelastic to paint price (labor >55% of paint cost). No adverse volume impact seen so far.

Demand trends and market sentiment — Akhilesh B, Northstar

Answered

Demand elasticity historically weak (paint is non-discretionary; bought once in 3-4 years). Prices flat for 2-3 years before this year's hikes. Demand recovery started post-Diwali 2025, accelerating. Not expecting margin headwind from demand.

Growth initiative details and competitive measures — Akhilesh B, Northstar

Partial

Most initiatives confidential. Not just discounting (small part). Includes influencer engagement with painters/contractors, higher A&P spend (reflect in Q2 +1% of sales). Results to show in Q3-Q4.

Jodhpur plant capex and double-digit growth — Uchit Garg, Individual

Answered

Jodhpur new plant 90KL, modern with automation. More capacity than old plant, automation not present before. Even at 'best case' top-line growth, won't need major capex next 2-3 yrs. Capacity utilization peaks ~75% Oct, drops ~50-55% off-season, ~60% average. No constraint.

Raw material hedging strategy — Uchit Garg, Individual

Answered

Hedging options not available for paint raw materials (unlike copper/aluminum). Not commodities like that. Forward buying not possible. Manage via inventory and pricing discipline.

Guidance

Forward guidance and management's confidence

No formal FY27 revenue target. Pursuing aggressive top-line growth 2x-3x industry growth.

Low

Hemant explicitly states 'I hesitate to give a number guidance.' Aspiration is 2x-3x but depends on industry growth (expects 12-15% in Q3). No FY27 end-target stated.

Gross margins to improve 'substantially' from Q3 onwards. EBITDA margins to 'normalize' H2.

Medium

High-cost inventory cleared by Aug; pass-through complete by Sept per call. Price hikes implemented/planned in Nov. Conditions: crude stable, no new raw material shocks.

Jodhpur plant ₹275 Cr spend (major capex now complete). No material capex required for next 2-3 years post-Jodhpur.

High

New plant 90KL capacity with automation eliminates need for major expansion. South India plant (commissioned 3 yrs ago) has excess capacity. Adequate for dual-digit growth.

Risks the call surfaced

Ranked by how much they should concern a holder

Raw material volatility

High

Crude has spiked twice (March-April 2026 +doubling, July-Aug climb). No forward buying or hedging available for paint raw materials. Q2 inventory shock shows pass-through lag.

Volume elasticity to price hikes

Medium

Two price hikes announced in Nov (+10-12% total from March). Management claims demand inelastic (paint <50% of total painting cost), but 3.5 yrs of price stability prior means customer behavior untested at this scale.

Jodhpur plant execution risk

Medium

Jodhpur trial production started late Sept 2026. Full commercial operation target is end-Nov, but timeline is loose ('end of Nov is when we'll declare trials over; it may happen 10-15 days earlier'). Automation debugging ongoing daily.

Inventory accounting volatility

Medium

Q1 benefited from expensing low-cost inventory purchased pre-March (EBITDA +42% YoY anomaly). Q2 reverse: high-cost inventory from March-April got expensed (-33% YoY). Management claims this is 'entirely because of the quirk of accountancy' but it masks operational volatility.

Margin recovery credibility

Medium

Management claims H2 EBITDA margin recovery to 'near normal' but avoids number guidance. Q4 typically strong (23% EBITDA margin historical). But Q3 recovery from -33% EBITDA growth is aggressive claim without quarterly target.

Management

Score 7/10. Clear on inventory mechanics and operational drivers (gross margin, product mix). Transparent about external volatility (geopolitical). Deliberately vague on number guidance ('I hesitate to give a number') to avoid repeat of prior missed targets. Defensive tone but honest. Jodhpur on schedule (trial Sept, full ops end-Nov). Gross margin recovery narrative credible (August recovery mentioned, Oct record sales). But Q2 miss on profitability (-47% PAT) shows execution gap vs market expectations.

What to watch next
  • 1 · Nov-Dec 2026

    Jodhpur plant full operational; gross margin stabilization

  • 2 · Q3 FY27 (Oct-Dec)

    Festive quarter strength + price hike absorption + inventory normalization

  • 3 · H2 FY27

    EBITDA margin recovery; outperformance vs industry if geopolitics stable

Jodhpur ramp real but risk of crude volatility and price-hike volume elasticity unproven.

Informational and educational content only. Not investment advice.